Sunday, April 19, 2026 | 07:51 AM ISTहिंदी में पढें
Vaxfab Enterprises Ltd
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
05:31 PM, 3rd May 2023
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 please note that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Right issue of the Company during the Quarter and year ended on 31st March 2023 as mentioned in the object clause of the Final Letter of Offer dated 7th January 2023. Please find enclosed herewith a statement in this regard.A statement confirming that there is no deviation or variation in the utilization of these proceeds is enclosed herewith.